Akers Biosciences Inc. (AKER)

[HokieHead]

Akers Biosciences: Here's Why The Licensing Deal With Premas Biotech Could Be A Game-Changer In The Race For A COVID-19 Vaccine

On March 25th, Akers Biosciences (NasdaqCM: AKER) announced a licensing agreement with Premas Biotech to find an effective vaccine for COVID-19. Premas Biotech has over 125 employees and has delivered over 650 proteins and has completed over 240 separate projects for pharmaceutical companies. The company also has four candidates currently in clinical trials globally, and most notable, an oral insulin drug candidate which recently completed a Phase 2b trial in the U.S.

The transcript from that announcement call explains exactly why Akers and Premas believe that the Akers Biosciences/Premas Biotech partnership has the potential to quickly and cost-effectively bring a yeast-based protein COVID-19 vaccine to market.

https://www.khits.com/story/41978191/akers-biosciences-heres-why-the-licensing-deal-with-premas-biotech-could-be-a-game-changer-in-the-race-for-a-covid-19-vaccine